RETA is currently covered by 8 analysts with average potential upside of $52.56 (62.14%) backed by 96 price targets and 97 ratings. Documented since 20-Jun-2016. Analyst's average stock valuation to be materialised ratio is 61.5% with an average time for price targets to be met of 196.36 days.
Most recent stock forecast was given by MADHU KUMAR from on 01-Mar-2023.
Highest price target for RETA is 122, Lowest price target is 21, average price target is 71.5.
Currently, out of the existing stock ratings of RETA - 29 which are a Buy (82.86%), 6 which are a Hold (17.14%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
185
$99.31 (115.89%)
117
26 days ago
7/11 (63.64%)
$57.97 (139.62%)
193
Buy
120
$34.31 (40.04%)
53
26 days ago
10/18 (55.56%)
$73.04 (79.84%)
242
Buy
121
$35.31 (41.21%)
68
26 days ago
7/14 (50%)
$47.71 (55.88%)
176
Hold
85
$-0.69 (-0.81%)
27
26 days ago
8/12 (66.67%)
$34.95 (40.37%)
185
Buy
90
$4.31 (5.03%)
50
26 days ago
3/4 (75%)
$19.29 (32.20%)
174
What is RETA(Reata Pharmaceuticals, Inc) average time for price targets to be met?
Which analyst has the current highest performing score on RETA(Reata Pharmaceuticals, Inc) with a proven track record?
